Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × UNKNOWN × Lymphoid × Clear all

Phase

Phase 2 8 Phase 4 2 Phase NA 1 Phase 3 1 Phase 1/2 1 Phase 1 1

Status

Sponsor Class

OTHER 852 INDUSTRY 63 OTHER_GOV 29 NIH 23 NETWORK 18 FED 3 INDIV 2 UNKNOWN 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 5 Thoracic 4 Breast 4 CNS 3 Other hematologic neoplasm 2 Sarcoma 1 Lymphoid 1 Gynecologic 1 Dermatologic 1

Conditions

Interventions

N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04511351 2020-08-13

Radiotherapy Combined With GDP With or Without Chidamide in Stage I/II Extranodal Nasal NK/T-cell Lymphoma

ChineseAMS

Phase NA Unknown

Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡